Science Explorer Back to mapMap
Discussion
Researcher · WinnMed · United States

Matthew Jankowski

Matthew Jankowski publishes mostly in Oncology, Surgery and Economics and Econometrics, on topics such as CAR-T cell therapy research, Economic and Financial Impacts of Cancer and Pancreatic and Hepatic Oncology Research.

OpenAlex
World rank
#5,295,218
of 7,710,434 ranked researchers
Rank in United States
#1,351,510
of 1,627,098
Works
18
Citations
20
Citations per work
1.1
h-index
3
i10-index 0Top 97% in Oncology
Matthew Jankowski

What does Matthew Jankowski research?

Matthew Jankowski's work is mostly in Medicine (45%), Economics, Econometrics and Finance (8%), Immunology and Microbiology (6%).

Health Sciences: 9 works · 49.0% of their workMedicine: 8 works · 44.7% of their workOncology: 5 works · 29.8% of their workSurgery: 2 works · 8.5% of their workOphthalmology: 1 works · 6.4% of their workHealth Professions: 1 works · 4.3% of their workGeneral Health Professions: 1 works · 4.3% of their workEverything else: 6 works · 36.1% of their workSocial Sciences: 2 works · 8.5% of their workEconomics, Econometrics and Finance: 2 works · 8.5% of their workEconomics and Econometrics: 2 works · 8.5% of their workLife Sciences: 1 works · 6.4% of their workImmunology and Microbiology: 1 works · 6.4% of their workImmunology: 1 works · 6.4% of their workTHEIR WORKMatthew Jankowski18works
Life Sciences6%Health Sciences49%Social Sciences8%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine844.7%
    2. Health Professions14.3%
  2. Everything else636.1%
    1. Economics, Econometrics and Finance28.5%
    1. Immunology and Microbiology16.4%
  1. 1Oncology30% of their works
  2. 2Surgery8% of their works
  3. 3Economics and Econometrics8% of their works
  4. 4Immunology6% of their works
  5. 5Ophthalmology6% of their works
  6. 6General Health Professions4% of their works

Research topics

Which keywords describe Matthew Jankowski's research?

The keywords of their largest research topics: Immunotherapy, CAR T Cells, Chemotherapy, Chimeric Antigen Receptor, Cost of Care, Financial Toxicity, Pancreatic Cancer and Surgical Complications.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Immunotherapy103 topics
  2. CAR T Cells51 topic
  3. Chemotherapy52 topics
  4. Chimeric Antigen Receptor51 topic
  5. Cost of Care41 topic
  6. Financial Toxicity41 topic
  7. Pancreatic Cancer31 topic
  8. Surgical Complications31 topic
  9. Genomic Profiles21 topic
  10. Implementation Science21 topic
  11. Network Analysis21 topic
  12. Psychopathology21 topic
  13. Qualitative Research21 topic
  14. Small-Cell Lung Cancer21 topic
  15. Biochemical Genetics11 topic
  16. Bioimage Analysis11 topic
  17. High-Content Screening11 topic
  18. Metabolic Disorders11 topic

Where does Matthew Jankowski work?

Matthew Jankowski's main affiliation in the publication record is WinnMed, United States.

How many publications and citations does Matthew Jankowski have?

OpenAlex counts 18 works and 20 citations for Matthew Jankowski, an h-index of 3, ranking #5,295,218 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Matthew Jankowski. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.